ALK and thyroid nodule: However, we noted that ALK fusion (8.3%) (p = 0.245), BRAF V600E (25.0%) (p = 0.001 *), and TP53 (25.0%) (p = 0.018 *) tend to associate with invasive/aggressive Bethesda III thyroid nodules.